Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market dynamics of STD testing devices are significantly influenced by the prevalence of sexually transmitted diseases and growing awareness about the importance of regular testing. As public awareness campaigns gain traction, there is a rising demand for convenient and accessible testing options.
Diagnostic technologies development impacts the testing devices market of STD. Advancement in rapid testing kits, point of care devices and home testing systems provide results in less time, which is more accurate and beneficial for the market, and all such advancement lead to positive dynamics in the market.
A conspicuous increase in home test STD kits is evident in the market. Home-based testing enables better comfort and opportunities that are but a click or a swift call away, worrying that will influence market dynamics to a major effect, as more and more people prone to them.
The globalization of healthcare as well as activities aimed at increasing access to tests in various regions creates market dynamics. Availability of STD testing devices also enables various developing countries to get better, contributing to the market demand.
Government programs and policies concerning sexual health affect greatly STD testing devices market. The key thing which should be considered it is namely important of such public health campaigns, subsidies, and regulatory frameworks in the shaping of market dynamics and the influence of consumer behavior as well.
STD testing devices’ integration with telehealth services has proved to be a revolutionary tendency. Remote consultations, digital prescriptions, home ordering and performing tests via telehealth are revolutionising market trends and providing ease of access to healthcare services.
The multiplex testing platforms that enable multiple screening STDs from a single sample have attract the attention. The impetus for such a trend is the requirement for all-comprehensive diagnosis, which in its turn affects the market dynamics in the direction to two-fold advantage – higher efficiency and value for money.
The fact that there is an increasing need for fast tests and point of care testing devices promotes market dynamics. Quicker outcomes decrease stress, make the opportunity to intervene promptly doable, and add to the stamina of the STD testing system, controlling the selection of testing devices both by medical specialists and lay individuals.
STI ways represent market dynamics. The application of these programs require dispersal of testing devices to individuals in the at-risk communities, thus affecting the market by creating a regular demand for testing products.
Whatever the matter cost or cost considerations factors also impact the STD testing devices adoption. The market dynamics are controlled by the easy accessibility of cheap alternative options especially in regions which are characterized with low allocation and availability of amenities.
Collaborations between private and public also contribute to the movement of markets. Collaborations between governments, not-for- profits, and private companies tend to produce breakthrough testing tools and wider disseminations.
Efforts to reduce the stigma associated with STD testing and educate users about the importance of regular screening influence market dynamics. A more informed and proactive approach to sexual health contributes to increased testing device adoption.
STD Testing Devices Market Highlights:
STD Testing Devices Market Forecast:
The STD Testing Devices Market is projected to reach USD 23.3 Billion by 2032 at 5.5% CAGR during the forecast period 2023-2032.
Market Synopsis
Sexually transmitted disease (STDs) is an infection caused due to some organisms. STDs can be transmitted from one person to another through sexual activity and intimate contact. The cases of sexually transmitted diseases keep climbing among 45 and older Americans. 82,938 cases of gonorrhea, syphilis, and chlamydia were reported among 45 and older Americans in the year 2016.
Market Influencer
The increasing prevalence of lifestyle diseases, rising geriatric population along with increasing awareness about sex-related diseases is influencing the market growth positively. The increasing number of product launches by key players in the market are likely to act as a promising factor for the increase in the near future. Â For Instance, Quest Diagnostics launched three new sexually transmitted disease (STD) laboratory test packages that individuals can purchase online for some of the most prevalent STDs in the United States.
Market Drivers
- Increase in prevalence of sex-related diseases
- Every year, 376 million new cases of chlamydia, syphilis, gonorrhea, and trichomoniasis are reported globally. The total estimated direct cost of STIs annually in the U.S. is about USD 16 billion.
- The most common STIs affecting a lot of people are Chlamydia, gonorrhea, and syphilis. Approximately 1.5 million cases of chlamydia were reported in 2015 in US alone which represents it to be the highest number of annual cases of any condition ever reported.
- A total of 89,239 cases of gonorrhea were reported by 27 states of the European Union in 2017.
- Increasing prevalence of lifestyle diseases
- Rise in healthcare expenditure
- Increasing geriatric population
- Increasing mergers & acquisitions by prominent players in the market
- For instance, in 2019, the US Food and Drug Administration (FDA) has cleared two tests "The Aptima Combo 2 Assay (Hologic Inc) and the Xpert CT/NG (Cepheid)" to detect Chlamydia trachomatis and Neisseria gonorrhoeae from throat and rectum samples.
- Increasing awareness about STIs
Market Restraints
- Lack of information about the symptoms and causes is hampering the growth of the market.
Segmentation
By Type
-
Laboratory Devices: It is expected to hold a larger share. Laboratory devices are the traditional methods of detecting STI and a large number of hospitals and clinics are expected to be using the laboratory devices.
-
Point of Care (POC) Devices: It is expected to be the fastest-growing segment as it is less time-consuming.
By End-User
-
Hospitals and Clinics: Hospitals and clinics segment dominates the global market for The positive growth of hospitals is attributed to factors such as high volume of STD tests performed in hospital-based laboratories across the globe and growing patient population.
-
Diagnostic Laboratories: Diagnostic Laboratories segment take up the second-largest share due to the rising number of diagnostic labs and the increasing patient population.
-
Research Laboratories and Institutes: segment is projected to be the fastest-growing segment over the assessment period. The research and development activities with respect to STD diagnostics and treatment have increased in last decade which has resulted in the growing demand for the devices and kits in the R&D facilities. Besides that, government funding for the research and development for effective treatment of STD has pushed the growth of this segment. The researchers from King's College London, have published a study in Nature Communications, according to them skin vaccination can generate protective CD8 T-cells that are recruited to the genital tissues and could be used as a vaccination strategy for sexually transmitted infections (STIs).
By Region
-
Americas: It is the largest regional market owing to the factors such as large patient population, rise in prevalence of STIs, the availability of a wide variety of STD testing kits and surges in awareness about the causes of STIs and its treatments which are driving the growth of the market in this region.- According to the Centers for Disease Control and Prevention (CDC), more than 1300 cases of congenital syphilis, about 40% increase was reported in newborns during 2017-2018 in US. Similarly, a rise in 8487 new cases of women suffering from gonorrhea in US alone was reported during the year 2017-2018.
-
Europe: The key factors driving the market growth are the growing research and development support by government bodies for the healthcare sector, and the significant demand for STI testing is driving the growth of the STI testing devices market in Europe. Additionally, the rising initiatives by organizations are driving market growth. For Instance, EuroTEST initiative is a platform for information exchange and activities to improve early diagnosis and care of HIV, viral hepatitis, sexually transmitted infections, and tuberculosis.
-
Asia-Pacific: The Asia-Pacific region is anticipated to be the fastest-growing region in the global STI testing devices market. The rising patient population is driving the growth of the Asia-Pacific STI testing devices market. Additionally, increasing disposable income of the middle-class population, and improving healthcare infrastructure in emerging countries such as China and India are driving the market growth. However, unfavorable healthcare reforms may restrain the growth of the market to some extent.
-
Middle East & Africa: This region is the smallest market due to limited healthcare infrastructure and limited exposure to technological advancements.
Key Players
- Abbott (US)
- MedMira Inc. (Canada)
- Qaigen Inc. (US)
- Thermo Fisher Scientific (US)
- Cepheid (Danaher Corporation) (US)
- Hoffmann-La Roche AG (Switzerland)
- Diasorin S.p.A (Italy)
- Bio-Rad Laboratories, Inc. (US)
- bioMeriuex (France)
- Becton Dickinson and Company (US)
- Hologic, Inc. (US)
- GenePOC Inc. (Canada)
- Meridian Bioscience (US)
- OraSure Technologies (US)
Â
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
